172 related articles for article (PubMed ID: 17876196)
1. Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.
Marchioli R; Marfisi RM; Borrelli G; Chieffo C; Franzosi MG; Levantesi G; Maggioni AP; Nicolosi GL; Scarano M; Silletta MG; Schweiger C; Tavazzi L; Tognoni G
J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S34-7. PubMed ID: 17876196
[TBL] [Abstract][Full Text] [Related]
2. Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction.
Verboom CN;
Herz; 2006 Dec; 31 Suppl 3():49-59. PubMed ID: 17575805
[TBL] [Abstract][Full Text] [Related]
3. [Omega-3 polyunsaturated fatty acids and cardiovascular diseases].
Marchioli R
Minerva Cardioangiol; 2003 Oct; 51(5):561-76. PubMed ID: 14551524
[TBL] [Abstract][Full Text] [Related]
4. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction.
Lamotte M; Annemans L; Kawalec P; Zoellners Y
Herz; 2006 Dec; 31 Suppl 3():74-82. PubMed ID: 17575809
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.
Marchioli R; Levantesi G; Macchia A; Marfisi RM; Nicolosi GL; Tavazzi L; Tognoni G; Valagussa F;
J Cardiovasc Med (Hagerstown); 2006 May; 7(5):347-50. PubMed ID: 16645413
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
Marchioli R; Schweiger C; Tavazzi L; Valagussa F
Lipids; 2001; 36 Suppl():S119-26. PubMed ID: 11837985
[TBL] [Abstract][Full Text] [Related]
7. [Results of GISSI Prevenzione: diet, drugs, and cardiovascular risk. Researchers of GISSI Prevenzione].
Marchioli R
Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):745-6. PubMed ID: 12503535
[No Abstract] [Full Text] [Related]
8. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.
Lancet; 1999 Aug; 354(9177):447-55. PubMed ID: 10465168
[TBL] [Abstract][Full Text] [Related]
9. [Heart failure and mortality: polyunsaturated fatty acids and the relevance of evidence].
Bausano G
Recenti Prog Med; 2011 Jan; 102(1):33-42. PubMed ID: 21516670
[TBL] [Abstract][Full Text] [Related]
10. Do fish oils or vitamin E reduce morbidity and mortality after myocardial infarction?
Rand PJ; Schooff M
J Fam Pract; 1999 Nov; 48(11):847-8. PubMed ID: 10907618
[No Abstract] [Full Text] [Related]
11. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids.
Macchia A; Levantesi G; Franzosi MG; Geraci E; Maggioni AP; Marfisi R; Nicolosi GL; Schweiger C; Tavazzi L; Tognoni G; Valagussa F; Marchioli R;
Eur J Heart Fail; 2005 Aug; 7(5):904-9. PubMed ID: 16087142
[TBL] [Abstract][Full Text] [Related]
12. Mediterranean diet and n-3 fatty acids in the prevention and treatment of cardiovascular disease.
de Lorgeril M; Salen P
J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S38-41. PubMed ID: 17876197
[TBL] [Abstract][Full Text] [Related]
13. n-3 Polyunsaturated fatty acids are still underappreciated and underused post myocardial infarction.
Khavandi A; Khavandi K; Greenstein A; Karsch K; Heagerty AM
Heart; 2009 Apr; 95(7):540-1. PubMed ID: 19131442
[No Abstract] [Full Text] [Related]
14. N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence.
Marchioli R; Silletta MG; Levantesi G; Pioggiarella R; Tognoni G
Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):110-30. PubMed ID: 20196975
[TBL] [Abstract][Full Text] [Related]
15. GISSI-Prevenzione trial.
Ng W; Tse HF; Lau CP
Lancet; 1999 Oct; 354(9189):1555-6; author reply 1556-7. PubMed ID: 10551521
[No Abstract] [Full Text] [Related]
16. Omega-3 polyunsatured fatty acids role in postmyocardial infarction therapy.
Imazio M; Forno D; Quaglia C; Trinchero R
Panminerva Med; 2003 Jun; 45(2):99-107. PubMed ID: 12855934
[TBL] [Abstract][Full Text] [Related]
17. [Recommendations for secondary prevention after myocardial infarction].
Arntz HR
Z Kardiol; 2004; 93 Suppl 1():I23-5. PubMed ID: 15022004
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial.
Marchioli R; Levantesi G; Macchia A; Maggioni AP; Marfisi RM; Silletta MG; Tavazzi L; Tognoni G; Valagussa F;
J Membr Biol; 2005 Jul; 206(2):117-28. PubMed ID: 16456722
[TBL] [Abstract][Full Text] [Related]
19. The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardio (GISSI)-Prevenzione Trial on fish oil and vitamin E supplementation in myocardial infarction survivors.
Stone NJ
Curr Cardiol Rep; 2000 Sep; 2(5):445-51. PubMed ID: 10980913
[TBL] [Abstract][Full Text] [Related]
20. N-3 fatty acids: priority for post-myocardial infarction clinical trials.
Grundy SM
Circulation; 2003 Apr; 107(14):1834-6. PubMed ID: 12695281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
